ANIK — Anika Therapeutics Inc · rev $62.2M

Anika Therapeutics Inc (ANIK) is a drug manufacturers - specialty & generic company listed on US.

Latest reported ANIK revenue for 2026-06-30 was $62.2M. Net income was -$1.7M. ANIK currently screens at market cap $161.3M.

Use this ANIK page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ANIK quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ANIK SEC filings page. Lician reads the product cache first so this HTML stays unique to Anika Therapeutics Inc even when a live quote feed is slow.

Anika Therapeutics Inc latest statements (FY2025)

Latest cached year on this hub. Full ANIK income, balance, and cash tables.

  • Revenue$112.8M
  • Net Income-$10.9M
  • Total Assets$190.3M
  • Total Debt$0
  • Free Cash Flow$4.4M

ANIK recent filings